(Press-News.org) University of British Columbia researchers have developed a vaccine that may halt the spread of West Nile Virus (WNV) among common and endangered bird species.
WNV, a mosquito borne pathogen, arrived in North America in 1999 and is now endemic across the continent. In 2012 alone, WNV killed 286 people in the United States, and 42 people have died from the virus in Canada since 2002. There is currently no effective vaccine against WNV infection in humans or birds.
Common birds such as crows, ravens and jays, and endangered species such as the Greater Sage-Grouse and the Eastern Loggerhead Shrike, are also susceptible to WNV infection, with mortality rates in some species and populations as high as 100 per cent.
"West Nile Virus has been identified as a threat contributing to the extinction of some rare bird species and its presence in common birds facilitates the spread of the disease," says Joanne Young , lead author of a study recently published in PLOS ONE and a PhD student in UBC's Michael Smith Laboratories and Department of Zoology. "A bird vaccine would go a long way to helping combat these adverse effects."
Young and Prof. Wilfred Jefferies developed and tested a vaccine made from components of WNV and found it generated an effective immune response in birds. This may protect against the spread of virus not only among birds but also to other species. The team will now study the vaccine's effectiveness in protecting birds against mortality caused by the disease.
###
Jefferies is a researcher in UBC's Michael Smith Laboratories, the Brain Research Centre, and the Centre for Blood Research at UBC. Jefferies is also a member of a UBC's departments of Medical Genetics, Microbiology and Immunology, and Zoology. Young was partially funded by a Commonwealth Scholarship.
Bird vaccine for West Nile Virus
2013-07-09
ELSE PRESS RELEASES FROM THIS DATE:
Double-barreled attack on obesity in no way a no-brainer
2013-07-09
In the constant cross talk between our brain and our gut, two gut hormones are already known to tell the brain when we have had enough to eat. New research suggests that boosting levels of these hormones simultaneously may be an effective new weapon in the fight against obesity.
Dr Shu Lin, Dr Yan-Chuan Shi and Professor Herbert Herzog, from Sydney's Garvan Institute of Medical Research, have shown that when mice are injected with PYY3-36 and PP, they eat less, gain less fat, and tend not to develop insulin-resistance, a precursor to diabetes. At the same time, the researchers ...
Graphene on its way to conquer Silicon Valley
2013-07-09
The unique properties of graphene such as its incredible strength and, at the same time, its little weight have raised high expectations in modern material science. Graphene, a two-dimensional crystal of carbon atoms packed in a honeycomb structure, has been in the focus of intensive research which led to a Nobel Prize of Physics in 2010. One major challenge is to successfully integrate graphene into the established metal-silicide technology. Scientists from the University of Vienna and their co-workers from research institutes in Germany and Russia have succeeded in fabricating ...
Technologies for monitoring remaining leukemia after treatment may help predict patient outcomes
2013-07-09
(WASHINGTON, July 9, 2013) – New evidence suggests that using advanced genetics technologies to monitor for remaining cancer cells after treatment may soon become an effective tool to inform treatment decisions and ultimately predict patient outcomes for patients with a particularly aggressive form of acute lymphocytic leukemia (ALL). Study results were published online today in Blood, the Journal of the American Society of Hematology (ASH).
Approximately 25 to 30 percent of all adults with ALL, the second most common type of acute leukemia, have what is known as Philadelphia ...
Are clinical trial data shared sufficiently today?
2013-07-09
Ben Goldacre, research fellow at the London School of Hygiene and Tropical Medicine, says we need all the evidence to make informed decisions about medicines.
The lack of progress on transparency has been startling, he writes. Current estimates suggest that around half of all trials for the treatments being used today have gone unpublished; and that trials with positive results are twice as likely to be published.
There is legislation mandating greater transparency – such as the law requiring trial results to be posted on the website clinicaltrials.gov – but the published ...
Suspicions confirmed: Brain tumors in children have a common cause
2013-07-09
Brain cancer is the primary cause of cancer mortality in children. Even in cases when the cancer is cured, young patients suffer from the stress of a treatment that can be harmful to the developing brain. In a search for new target structures that would create more gentle treatments, cancer researchers are systematically analyzing all alterations in the genetic material of these tumors. This is the mission of the PedBrain consortium, which was launched in 2010. Led by Professor Stefan Pfister from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), ...
GR20/Amaldi10: Space-time is not the same for everyone
2013-07-09
Before the Big Bang, space-time as we know it did not exist. So how was it born? The process of creating normal space-time from an earlier state dominated by quantum gravity has been studied for years by theorists at the Faculty of Physics, University of Warsaw. Recent analyses suggest a surprising conclusion: not all elementary particles are subject to the same space-time.
Several billion years ago, in the era soon after the Big Bang, the Universe was so dense and so hot that elementary particles felt the existence of gravity strongly. For decades, physicists around ...
RUB researchers decode the interplay between enkephalins and pain receptors
2013-07-09
"Pain begone!" In order to send out this signal, the human body produces tiny messenger molecules that dock to certain receptors. Using traditional biochemical methods, this interaction between the messengers, so-called enkephalins, and opioid receptors is very difficult to study. An interdisciplinary team of biochemists and inorganic chemists at the Ruhr-Universität Bochum (RUB) has now succeeded in identifying the structure of an enkephalin in solution and to track its interaction with the opioid receptor in detail. The analysis provides a new, precise starting point ...
Researchers build 3-D structures out of liquid metal
2013-07-09
Researchers from North Carolina State University have developed three-dimensional (3-D) printing technology and techniques to create free-standing structures made of liquid metal at room temperature.
"It's difficult to create structures out of liquids, because liquids want to bead up. But we've found that a liquid metal alloy of gallium and indium reacts to the oxygen in the air at room temperature to form a 'skin' that allows the liquid metal structures to retain their shapes," says Dr. Michael Dickey, an assistant professor of chemical and biomolecular engineering at ...
Big name for a small worm
2013-07-09
This news release is available in German. An unusual posthumous honour for physicist Max Planck: Biologists in Tübingen working with Ralf J. Sommer have named a newly discovered nematode after the German Nobel laureate. Pristionchus maxplancki is thus the first species to carry the name of the scientist, who died in 1947. The discovery from the Far East is assisting the researchers of the Max Planck Institute for Developmental Biology to attain new insights and knowledge about the many interdependencies between evolution, genetics, and ecology.
When Japanese biologist ...
Contaminated ultrasound gel tied to outbreak of healthcare-associated infections
2013-07-09
CHICAGO (July 9, 2013) – After a 2011 outbreak of P. aeruginosa, investigators at Beaumont Health System near Detroit, Michigan determined contaminated ultrasound gel was the source of bacteria causing the healthcare-associated infection. The findings emphasize the need for increased scrutiny of contaminated medical products. This study is published in the August issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
"Ultrasound is a critical healthcare tool used every day in both diagnostic and interventional ...